serum carnosinase Inhibitors

Serum carnosinase inhibitors represent a distinct chemical class known for their ability to modulate the activity of the enzyme serum carnosinase, also referred to as CN1 or serum carnosinase 1. This class of compounds plays a pivotal role in controlling the degradation of carnosine, a naturally occurring dipeptide consisting of beta-alanine and histidine found in the human body. Carnosine possesses a range of physiological functions, including antioxidant properties and potential neuroprotective effects. However, serum carnosinase rapidly breaks down carnosine, limiting its biological impact.

Serum carnosinase inhibitors bind to the active site of the enzyme serum carnosinase, forming stable complexes that hinder the enzyme's capacity to interact with carnosine molecules. As a result, these inhibitors effectively elevate the concentration of carnosine in the bloodstream and various tissues, allowing carnosine to potentially manifest its various biological benefits.